SOStela Odobescu

Stela Odobescu

*This is an algorithmically generated author record based on publicly available information.

Stela Odobescu has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Risk factors of stroke in young adults: a retrospective cohort study

    by Gabriela Nacu, Stela Odobescu, Ion Moldovanu, Galina Corcea, Adrian Lupusor, Svetlana Lozovanu, Victor Vovc, Oxana Grosu

    Introduction: The incidence of ischemic stroke in young adults (defined by several studies as the population aged 1850) accounts for approximately 15% - 18% of the total number of ischemic stroke cases. Many studies have highlighted the significant impact of traditional vascular risk factors in the etiology of ischemic stroke among the young adult population. Purpose: To assess the risk factors and causes of ischemic stroke among young adults in an institutional cohort. Materials and Methods: A retrospective cohort study was conducted using the electronic data registry of the Institute of Neurology and Neurosurgery, by analyzing medical records of patients hospitalized with a diagnosis of ischemic stroke between October 2017 and February 2022. Predominantly traditional risk factors were analyzed in young adults with ischemic stroke. Results: From 2056 medical records analyzed, 79 patients (3.8%) were identified as young adults, 55 males and 24 females, with an average age of 43.24 ± 7.35 [min 21; max 50]. 65 patients (82.3% of cases) were diagnosed with primary ischemic stroke, and 14 patients (17.7% of cases) with recurrent ischemic stroke. The most frequent traditional risk factors found among young adults were hypertension (75.9% - 60 patients), dyslipidemia (36.7% - 29 patients), the presence of atherosclerotic plaques (34.2% - 27 patients, of which 10 had occlusions), smoking (30.4% - 24 patients), obesity (29.1% - 23 patients), and type II diabetes (21.5% - 17 patients). 27 individuals had high total cholesterol levels, and 16 individuals had high triglyceride levels. For prevention, antihypertensive treatment was administered by only 33 patients (41.8%), antithrombotic therapy -- by 22 patients (27.85%), and lipid-lowering drugs by 8 patients (10.1%). Conclusions: Like other studies, ours shows a high prevalence of traditional, potentially modifiable risk factors for ischemic stroke in young adults, so it highlights the need of implementation of more rigorous national prevention measures and control of risk factors, particularly for young individuals.

  • The Evolution of Acute Cerebrovascular Disease Patient Management in the Post-COVID-19 Period: A Systematic Review

    by Diana Zetu-Buciuscan, Elena Manole, Elena Costru-Tasnic, Lilia Rotaru, Stela Odobescu, Oxana Grosu

    Stroke represents a major public health issue, causing millions of deaths annually and generating a significant burden in terms of disability. The COVID-19 pandemic profoundly influenced the management of patients with acute stroke, leading to reduced hospital admissions and delays in therapeutic procedures. Studies have shown a decrease in thrombolysis and thrombectomy during the early months, as well as prolonged critical intervals such as "onset-to-door" and "door-to-CT," mainly due to epidemiological measures and the mandatory use of protective equipment. In the post-pandemic period, healthcare systems have adapted their protocols, with some being maintained and others discontinued. Recent data indicate improvements in "door-to-needle" times and more efficient clinical workflows. At the same time, the persistence of post-COVID vascular risk complicates patient outcomes, as SARS-CoV-2 infection has been shown to double cardiovascular risk up to three years after the acute episode, with vaccination significantly mitigating these adverse effects. Innovative methods, such as rapid tests for detecting large vessel occlusions and the expansion of telestroke networks, are modernizing therapeutic strategies. The systematic review of literature published between 2020-2025 highlights regional variability in service organization but also demonstrates a clear trend toward improved efficiency in the post-pandemic era. Conclusions emphasize the need to strengthen telemedicine, standardize protocols, and minimize therapeutic delays to optimize outcomes for stroke patients.

  • Management of patients with neurodegenerative diseases in the post-COVID-19 era: lessons learned and future directions

    by Madalina Cebuc, Lilia Rotaru, Stela Odobescu, Ion Moldovanu, Galina Corcea, Oxana Grosu

    Background: Neurodegenerative diseases (NDs) are progressive disorders with a major impact on autonomy and quality of life, and the COVID-19 pandemic has exacerbated their burden by limiting access to care. Objective: To synthesize post-pandemic data and clinical experience to propose directions for optimizing the management of patients with NDs. Methods: The study used a mixed-methods approach, combining a narrative literature review (PRISMA, PubMed/ Scopus, 2024-2025) and in-depth interviews with neurologists, patients, and caregivers at the "Diomid Gherman" Institute of Neurology and Neurosurgery, analyzed thematically. Results: Analysis of the included articles (n=10) and interviews (neurologists n=7; patients and caregivers n=15) identified four main directions: service adaptation, social impact and isolation, changes in individual care environments, and perspectives on the healthcare system, highlighting the digitalization of consultations, the development of home- and community-based care, and persistent gaps in access to multidisciplinary management in the Republic of Moldova. Conclusion: The findings emphasize the need to strengthen resources and standardize services to ensure equitable, patient-centered management of NDs in the post-pandemic period

  • Early Cognitive Impairment in Parkinson’s Disease – Exploring the Vascular Contribution

    by Lilia Rotaru, Mădălina Cebuc, Oxana Grosu, Stela Odobescu, Ion Moldovanu, Adrian Lupușor, Ion Grabovschi, Svetlana Lozovanu, Ghenadie Cărăușu, Tatiana Pleșcan, et al.


  • Use of criteria for post-covid-19 intracerebral thrombosis: a case series. The diagnosis of post-COVID-19 cerebral venous thrombosis (CVT) in adults is made

    by Cornelia Țurcan, Oxana Grosu, Lilia Rotaru, Stela Odobescu, Ion Moldovanu

    The diagnosis of post-COVID-19 cerebral venous thrombosis (CVT) in adults is made according to the following criteria: (1) age ≥18 years; (2) CVT confirmed by imaging or autopsy; (3) COVID-19 confirmed by PCR test 90 days before CVT diagnosis or during hospitalization. Purpose of the paper: Analysis of the utility of diagnostic criteria for establishing the diagnosis of post-COVID-19 cerebral thrombosis. Material and Methods: The cases of all patients suspected of CVT, admitted to the Institute of Neurology and Neurosurgery “Diomid Gherman” in 2020 - 2023 were evaluated. The application of diagnostic criteria was analyzed. Results and discussions: 5 patients aged 30-66 years were identified, diagnosed with post-COVID-19 CVT confirmed by PCR test. Complaints presented upon admission were: sudden onset severe headache, diplopia, retroorbital pain, exophthalmos, ataxia. Investigations performed were: computed tomography (CT) angiography, contrast-enhanced cerebral magnetic resonance imaging (MRI), digital subtraction angiography of the head, classical angiography. CVT was determined at the level of the transverse and cavernous sinus. The average time from confirmation of COVID-19 to the onset of CVT was 93 days. Of these patients, one presented ischemic stroke with hemorrhagic transformation in the vertebrobasilar system, user of oral contraceptives, with a history of migraine with aura; another presented secondary bacterial meningitis. Anticoagulant treatment was initiated, and some patients additionally received antibiotics. Conclusions. Cerebral venous thrombosis should be suspected in all post-COVID-19 patients. The use of diagnostic criteria can facilitate early diagnosis and prompt and correct therapeutic approach to patients.

  • Neurological clinical presentation of long COVID syndrome

    by Oxana Grosu, Cornelia Turcan, Lilia Rotaru, Stela Odobescu, Ion Moldovanu

    Patients who have suffered from COVID-19 after a certain time report a wide range of new or persistent symptoms (symptoms that persist for at least 12 weeks) called “long COVID-19 syndrome”. Aim: Narrative review regarding post-Covid-19 symptomatology to establish the clinical variability. Material and Methods: To achieve the purpose of the study, a systematic analysis of literature data on the given topic was performed. Thus, scientific sources were studied in the scientific citation databases PubMed, Google Scholar, Web of Science, eLibrary. Results and discussions: According to the studies analyzed, most patients most often manifest fatigue, cognitive disorders and sleep disorders, less often present other neurological disorders (headache, anxiety, depression, etc.). Patients with long COVID-19 syndrome report sleep disorders such as insomnia or drowsiness. These people have greater difficulty falling asleep at the desired time and also waking up at the desired time. In some patients, sleep disorders were present even after 12 months after Covid-19, with a negative impact on the quality of life of patients. Headache is one of the earliest and most common symptoms of long COVID-19 syndrome. The presence of headache in the acute phase of Covid-19 infection was considered a positive prognosis, being associated with lower severity and mortality. Headache may persist to a significant extent in the long term. Depression and anxiety may be more a result of the severity of the illness and psychological trauma following the pandemic than a result of the viral infection. Anxiety and depression have significant long-term consequences. Conclusions: Long COVID syndrome is a complex condition with prolonged heterogeneous symptoms. Our study suggests the presence of fatigue, cognitive impairment, sleep disorders, headache, anxiety, and depression in the neurological symptomatology of long Covid syndrome. The persistence of long-term symptomatology highlights the importance of a holistic and continuous approach to better understand the impact of this disease on health and establish appropriate management.

  • Neurological complications post – COVID-19 vaccination

    by Ina Cojocaru, Oxana Grosu, Lilia Rotaru, Galina Corcea, Stela Odobescu, Ion Moldovanu

    Following vaccination of the population against Covid-19 infection, a multitude of neurological complications have been reported, from the most frequently encountered to the rarest. In our article we present a narrative analysis of two databases: PubMed and Google Scholar for all types of published studies (case reports, case series, cross-sectional study with a meta-analytic literature review, systematic review, meta-analysis, retrospective study, cohort study). Headache is one of the most publicized, early onset complications, it can be migraine type - 51.1% and tension type - 27.4%, most frequently starting after the administration of the AstraZeneca vaccine, followed by the Sputnik V vaccine. The incidence of ischemic stroke was recorded from 0.29 to 1.76 million vaccinees, while hemorrhagic stroke represents 364.7 per 1 million people, developing more frequently after mRNA vaccines. MOG encephalomyelitis was also recorded postvaccination, manifested by optic neuritis, with onset 10 days after the 1st dose administered, more susceptible being after the AstraZeneca vaccine. Acute disseminated encephalomyelitis (ADEM) was reported after the SinoVac and AstraZeneca vaccines, manifesting as sensory disturbances, seizures, and focal neurological deficits. GBS after COVID-19 vaccination occurs in 8.1 per 1,000,000 vaccinations, more frequently after mRNA vaccines. Optic neuritis occurs after inactivated vaccines, adenoviral vaccines, and messenger RNA vaccines, while multiple sclerosis begins after the administration of Pfizer and AstraZeneca vaccines. Transverse myelitis and Bell’s palsy are more common with the Moderna vaccine, while sinus thrombosis and TIA develop more often after the Johnson-Johnson vaccine.

  • Neurological complications post – COVID-19 infection

    by Ina Cojocaru, Oxana Grosu, Lilia Rotaru, Galina Corcea, Stela Odobescu, Ion Moldovanu

    The Sars-CoV-2 virus is from the coronavirus group with an affinity for affecting several systems, such as respiratory, cardiovascular, renal, gastrointestinal. A special role belongs to the nervous system, this infection involving the central nervous system (CNS) and the peripheral nervous system (PNS). The main viral transmission routes are the peripheral, hematogenous and lymphatic routes. Angiotensin convertase 2 (ACE2) has an essential role in the pathogenesis of Covid-19, underlies the inflammatory mechanisms and the so-called “cytokine storms”, influencing the development of coagulopathies and subsequent complications, with viral invasion of brain tissue due to crossing the blood-brain barrier. In the article, we analysed the main routes of viral invasion, as well as the neurological complications developed, involving both the central and peripheral nervous systems.

  • Neurological services in the post-pandemic period

    by Cătălina Gutu, Oxana Grosu, Galina Corcea, Lilia Rotaru, Stela Odobescu, Ion Moldovanu

    The Covid-19 pandemic has become an enormous challenge for the entire medical system. After the global vaccination campaign, humanity is returning to normal life, but the impact and changes it has produced are still palpable. The aim of the research is to analyse how neurological practice has changed after the end of the Covid-19 pandemic. Materials and methods. The literature review was conducted in accordance with the PRISMA criteria. The databases used to search for articles were Google Scholar and PubMed, for this purpose the following keywords were used: “tele neurology”, “pandemic”, “research”, “Tele Education”, “technology”. Articles published between 2020 and 2024, in European languages, were considered eligible. After evaluating the abstracts and titles, 44 articles were selected. Discussions. The pandemic created premises for the rapid implementation of Teleneurology, Tele Education and the digitalization of neurological services, facilitating the population’s access to them. Virtual platforms for consultations, communication, courses and conferences were identified or created. Technologization and digitalization have gained a new dimension, overcoming the barriers artificially imposed before the pandemic, demonstrating their usefulness including through clinical studies. The restrictions have forced neurologists to become more flexible and creative. Conclusions: Paradoxically, despite the restrictions imposed by the pandemic, neurological services and continuing medical education have now become more accessible through the widespread implementation of digital technologies. However, their introduction as routine practice requires careful assessment of the risks and benefits.


  • Open Access

    Circadian variations of neurotransmitters and cognitive dysfunction

    by Irina Iurcu, Adrian Lupushor, Madalina Cebuc, Lilia Rotaru, Stela Odobescu, Oxana Grosu, Svetlana Lozovanu, Ion Moldovanu, Victor Vovc

    To anticipate and adapt to recurring daily events driven by the earth’s rotation, organisms exhibit regulatory mechanisms designed to control homeostasis under different lighting conditions, called circadian rhythm (CR).The CR represents an endogenous biological network that coordinates 24-hour cycles at the genetic, biochemical, physiological, and behavioral levels. CR control systems transmit timing signals throughout the organism, with all internal processes exhibiting a daily maximum and minimum activity level managed through modulation of neurotransmission in critical neural structures.Knowing the daily variations of neurotransmitter activity in the central nervous system is essential in establishing effective neuroprotection mechanisms. This study summarizes current knowledge on the interplay between circadian rhythm, neurotransmitter fluctuations, and their impact on neuroprotection and mental health.